This non-interventional descriptive study was undertaken to better understand the most common imaging features associated with inflammation arising in the post-marketing setting when brolucizumab was prescribed in routine clinical practice.
Age range
18 Years – 105 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Eye case classification based on imaging data
Timeframe: throughout the study period of 5 months
Number of eye cases by anatomical location and sub-location
Timeframe: throughout the study period of 5 months
Number of eye cases by occlusion type by reading center eye case classification
Timeframe: throughout the study period of 5 months
Number of eye cases by Anatomical location in relation to macula
Timeframe: throughout the study period of 5 months
Number of eye cases by extent of involvement of the retinal arterial and vein occlusion
Timeframe: throughout the study period of 5 months
Number of eye cases by grading variables per imaging modality by reading center eye case classification
Timeframe: throughout the study period of 5 months